Bivictrix Therapeutics PLC - Macclesfield, England-based biotechnology company focused on cancer therapies - Says final sequences have been selected for its second programme BVX002, an antibody drug...

Related Keywords

Emma Curzon , Alliance News , Bivictrix Therapeutics , Alliance News Ltd , Executive Officer Tiffany Thorn , Acute Myeloid Leukaemia , All Rights , Markets ,